Technical Analysis for ESTA - Establishment Labs Holdings Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 48.20 | 0.12% | 0.06 |
Earnings due: Aug 6
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Flat | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 50 DMA | Bullish | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| 50 DMA Resistance | Bearish | 0.12% | |
| Upper Bollinger Band Walk | Strength | 0.12% | |
| Outside Day | Range Expansion | 0.12% | |
| Upper Bollinger Band Touch | Strength | 0.12% | |
| 50 DMA Resistance | Bearish | 0.88% |
| Alert | Time |
|---|---|
| Upper Bollinger Band Resistance | about 11 hours ago |
| 60 Minute Opening Range Breakdown | about 12 hours ago |
| Gapped Up (Full) | about 13 hours ago |
| Rose Above Previous Day's High | about 13 hours ago |
| Rose Above Upper Bollinger Band | about 13 hours ago |
Get a Trading Assistant
- Earnings date: 08/06/2024
Establishment Labs Holdings Inc. Description
Establishment Labs (ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica and currently sold in over 60 countries through exclusive distributors or a direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA to initiate the Motiva Implant® clinical trial in the United States. In addition to Motiva Implants®, Establishment Labs’ product and technologies portfolio includes Divina® 3D Simulation System, Puregraft, and MotivaImage® Centers.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Medical Technology FDA Prosthetics Implant Silicone Aesthetics Patient Safety Biological Engineering Breast Surgery Simulation System Breast Implant Investigational Device Exemption
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 73.0 |
| 52 Week Low | 17.0 |
| Average Volume | 317,091 |
| 200-Day Moving Average | 40.53 |
| 50-Day Moving Average | 48.04 |
| 20-Day Moving Average | 45.75 |
| 10-Day Moving Average | 47.34 |
| Average True Range | 2.57 |
| RSI (14) | 55.56 |
| ADX | 17.96 |
| +DI | 26.08 |
| -DI | 14.58 |
| Chandelier Exit (Long, 3 ATRs) | 44.71 |
| Chandelier Exit (Short, 3 ATRs) | 50.07 |
| Upper Bollinger Bands | 49.56 |
| Lower Bollinger Band | 41.94 |
| Percent B (%b) | 0.82 |
| BandWidth | 16.65 |
| MACD Line | 0.37 |
| MACD Signal Line | -0.15 |
| MACD Histogram | 0.5146 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 51.55 | ||||
| Resistance 3 (R3) | 51.90 | 51.14 | 50.99 | ||
| Resistance 2 (R2) | 51.14 | 50.29 | 50.96 | 50.80 | |
| Resistance 1 (R1) | 49.67 | 49.76 | 49.29 | 49.32 | 50.62 |
| Pivot Point | 48.91 | 48.91 | 48.72 | 48.73 | 48.91 |
| Support 1 (S1) | 47.44 | 48.06 | 47.06 | 47.09 | 45.78 |
| Support 2 (S2) | 46.68 | 47.53 | 46.50 | 45.60 | |
| Support 3 (S3) | 45.21 | 46.68 | 45.41 | ||
| Support 4 (S4) | 44.86 |
